Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

UNKNOWN

ReIMAGINE Prostate Cancer Risk

Lead Sponsor:

University College, London

Collaborating Sponsors:

Medical Research Council

Cancer Research UK

Conditions:

Prostate Cancer

Eligibility:

MALE

18-90 years

Brief Summary

ReIMAGINE Prostate Cancer Risk is a multi-centre, prospective, observational, longitudinal cohort study of men referred to secondary care with a suspicion of prostate cancer. The aim of the study is t...

Detailed Description

ReIMAGINE Prostate Cancer Risk is a multi-centre, prospective, observational, longitudinal cohort study of men referred to secondary care with a suspicion of prostate cancer or men who are undergoing ...

Eligibility Criteria

Inclusion

  • Any man with PSA 20 or less (value recorded \<90 days before study entry)
  • Men who have undergone a prostate MRI as a standard NHS diagnostic work-up
  • MRI lesion conforming to Likert/PIRADS 3, 4 or 5
  • Radiological stage T3b or less
  • Clinical or radiological stage N0 and M0
  • No anti-androgen exposure in the preceding 6 months (5-alpha reductase inhibitors permitted)
  • No prior treatment for prostate cancer (chemical, biological, ablative, surgical, radiotherapy)
  • Previous trans urethral resection of the prostate (TURP) is permitted
  • Willing and able to provide written informed consent.

Exclusion

  • Men unable to donate tissue, blood or urine.
  • Previous prostate cancer treatment
  • Previous prostate biopsy \<12 months from date of the mpMRI scan used to assess study eligibility (scoring PIRADS/Likert 3, 4 or 5)

Key Trial Info

Start Date :

September 3 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 31 2025

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT04060589

Start Date

September 3 2019

End Date

May 31 2025

Last Update

March 22 2023

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

University College London Hospital

London, United Kingdom, NW1 2PG

2

Royal Free Hospital

London, United Kingdom, NW3 2QG

3

Charing Cross Hospital

London, United Kingdom, W6 8RF